EFG Asset Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-169,926
Closed -$1.94M 182
2022
Q4
$1.94M Buy
169,926
+14,524
+9% +$215K 0.44% 79
2022
Q3
$2.65M Buy
155,402
+19,462
+14% +$418K 0.61% 53
2022
Q2
$2.92M Buy
135,940
+30,000
+28% +$832K 0.62% 55
2022
Q1
$3.92M Buy
105,940
+28,942
+38% +$1.13M 0.59% 56
2021
Q4
$3.5M Buy
+76,998
New +$4.02M 0.46% 62

Other funds holding CDNA

EFG Asset Management's CDNA Position: Q1 2023 in Review

EFG Asset Management sold out of CareDx (CDNA) in Q1 2023, closing a stake of 169,926 shares — an estimated $1.94M sold.

EFG Asset Management first reported a position in CDNA in Q4 2021 and held it in 5 quarters. The position peaked at $3.92M in Q1 2022. 156 funds tracked by Wall St. Rank hold CDNA as of Q1 2023.

  • EFG Asset Management reported no remaining CareDx position as of Q1 2023 after selling out during the quarter.
  • EFG Asset Management sold 169,926 CareDx shares in Q1 2023, an estimated $1.94M.
  • EFG Asset Management first reported a position in CareDx in Q4 2021 and held it in 5 quarters.
  • EFG Asset Management's CareDx position peaked at $3.92M in Q1 2022.
  • 156 funds tracked by Wall St. Rank held CareDx as of Q1 2023.

Based on EFG Asset Management's 13F filing for Q1 2023, filed 27 Apr 2023.